Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Grand River Aseptic Manufacturing Raises Funds for Expansion

Jun 17, 2014

Funding boosts life-sciences manufacturing in West Michigan.

Catalent and AAPS Announce Winners of Annual Academic Competition

Jun 13, 2014

Catalent and AAPS announce the five winners of its annual academic competition.

Merck to Acquire Idenix

Jun 11, 2014

Merck acquires Idenix Pharmaceuticals for $3.85 billion.

Xcelience Opens European Packaging and Distribution Facility

Jun 11, 2014

Xcelience opens a clinical packaging and distribution facility in Birmingham, UK.

USP Helps Expand Worldwide Access to Tuberculosis Drugs

Jun 11, 2014

USP and USAID give prequalification status to Capreomycin, an anti-tuberculosis injectable.

Cellectis Enters Agreement With CELLforCURE

Jun 11, 2014

Cellectis enters an agreement with CELLforCURE for cGMP clinical manufacturing of allogeneic T-cells.

USP Welcomes New Partners to "Fight the Fakes" Campaign

Jun 9, 2014

Eleven new organizations join the global "Fight the Fakes" campaign.

Malvern Instruments to Acquire MicroCal

Jun 5, 2014

Malvern Instruments will acquire the MicroCal business from GE Healthcare Life Sciences.

Bayer Extends CEO Contract

Jun 5, 2014

Bayer extends its CEO contract with Marijn Dekkers until 2016.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here